|
|
THE TOP NEWS IN MARIJUANA LAW REFORM
Volume 22 • Issue 49 • December 12, 2019
|
|
|
Researchers reported: "For the first time, we show a statistically significant negative association between recreational access to cannabis and OTC sleep aid sales.
|
|
|
|
|
|
Investigators concluded, "Results suggest that cannabis use may not cause decline in cognitive ability among a normative sample of cannabis users."
|
|
|
|
|
|
Compared to placebo, patients receiving CBD therapy experienced symptomatic improvements and reported no adverse effects.
|
|
|
|
Researchers concluded, "Our results show that cannabis was well tolerated by most of our patients... [and that] most of the patients were satisfied with the treatment."
|
|
|
|
|
|
"These findings are consistent with increased access to marijuana leading to substitution away from alcohol to marijuana."
|
|
|
|
Beginning in August 2020, those diagnosed with chronic pain and/or age-related macular degeneration will be eligible to receive medical cannabis recommendations.
|
|
|
|
|
|
|
Twenty-three percent of the products possessed significantly lower percentages of CBD than advertised.. An additional 11 percent of products contained no identifiable level of CBD.
|
|
|
|
|
|
Study: Marijuana Retailers Not Selling to Underage Customers Details
12/11/19 3:46pm UTC
Former State Rep. Diane Russell on Maine’s Cannabis Legalization Woes Details
12/10/19 9:50pm UTC
New Jersey cannabis consumers seek relief before 2020 Details
12/06/19 3:06pm UTC
Clinical Trial: Transdermal Application of CBD Effective in Patients with Myofascial Pain Details
12/06/19 2:35pm UTC
|
|
|
|
|
|
|
Sent via ActionNetwork.org.
To update your email address, change your name or address, or to stop receiving emails from NORML, please click here.
|
|
|
|